Veronica C. Munk

772 total citations
12 papers, 556 citations indexed

About

Veronica C. Munk is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Veronica C. Munk has authored 12 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Veronica C. Munk's work include Renin-Angiotensin System Studies (3 papers), Lung Cancer Research Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Veronica C. Munk is often cited by papers focused on Renin-Angiotensin System Studies (3 papers), Lung Cancer Research Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Veronica C. Munk collaborates with scholars based in Switzerland, United States and United Kingdom. Veronica C. Munk's co-authors include Natasha B. Leighl, Solange Peters, Christin Bexelius, Rok Humar, Edouard Battegay, Florian W. Kiefer, Aijing Shang, Weimin Li, Mary McCormack and Virginia M. Rosen and has published in prestigious journals such as Hypertension, Journal of the American Society of Nephrology and Experimental Cell Research.

In The Last Decade

Veronica C. Munk

12 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Veronica C. Munk Switzerland	10	233	221	158	80	65	12	556
Delma Verón United States	11	72 0.3×	87 0.4×	306 1.9×	55 0.7×	79 1.2×	15	621
John S. Moody United States	14	300 1.3×	298 1.3×	110 0.7×	223 2.8×	39 0.6×	22	894
Sonia L. Villegas United States	15	95 0.4×	117 0.5×	272 1.7×	251 3.1×	45 0.7×	25	654
Yasuhiro Ohshima Japan	19	181 0.8×	201 0.9×	383 2.4×	40 0.5×	23 0.4×	41	1.1k
Yufeng Ren China	14	92 0.4×	129 0.6×	166 1.1×	128 1.6×	13 0.2×	40	592
K Schubert Germany	13	211 0.9×	57 0.3×	134 0.8×	24 0.3×	23 0.4×	52	602
Jun Feng China	15	105 0.5×	165 0.7×	330 2.1×	71 0.9×	93 1.4×	43	800
Bing Sun China	19	482 2.1×	380 1.7×	254 1.6×	28 0.3×	22 0.3×	76	1.1k
Sara Alberti Italy	11	40 0.2×	210 1.0×	147 0.9×	76 0.9×	22 0.3×	20	531
Eva Tarantino Italy	15	160 0.7×	104 0.5×	194 1.2×	81 1.0×	18 0.3×	18	596

Countries citing papers authored by Veronica C. Munk

Since Specialization

Citations

This map shows the geographic impact of Veronica C. Munk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica C. Munk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica C. Munk more than expected).

Fields of papers citing papers by Veronica C. Munk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica C. Munk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica C. Munk. The network helps show where Veronica C. Munk may publish in the future.

Co-authorship network of co-authors of Veronica C. Munk

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica C. Munk. A scholar is included among the top collaborators of Veronica C. Munk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica C. Munk. Veronica C. Munk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Batson, Sarah, et al.. (2017). Tyrosine kinase inhibitor combination therapy in first-line treatment of non-small-cell lung cancer: systematic review and network meta-analysis. OncoTargets and Therapy. Volume 10. 2473–2482. 36 indexed citations

Rosen, Virginia M., Mary McCormack, Angélica Nogueira‐Rodrigues, et al.. (2017). Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer. International Journal of Gynecological Cancer. 27(6). 1237–1246. 65 indexed citations

Peters, Solange, Christin Bexelius, Veronica C. Munk, & Natasha B. Leighl. (2016). The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer. Cancer Treatment Reviews. 45. 139–162. 195 indexed citations

Roughley, Adam, et al.. (2014). Impact of Brain Metastases on Quality of Life and Estimated Life Expectancy in Patients with Advanced Non-Small Cell Lung Cancer. Value in Health. 17(7). A650–A650. 22 indexed citations

Lowy, A, Veronica C. Munk, Michel Burnier, et al.. (2010). Effects on blood pressure and cardiovascular risk of variations in patients’ adherence to prescribed antihypertensive drugs: role of duration of drug action. International Journal of Clinical Practice. 65(1). 41–53. 31 indexed citations

Delea, Thomas E., Oleg Sofrygin, James L. Palmer, et al.. (2009). Cost-Effectiveness of Aliskiren in Type 2 Diabetes, Hypertension, and Albuminuria. Journal of the American Society of Nephrology. 20(10). 2205–2213. 18 indexed citations

Kario, Kazuomi, Adam Lowy, Veronica C. Munk, & Lieven Annemans. (2009). 24-Hour Blood Pressure Control – A Predictor for Clinical Outcomes. Current Hypertension Reviews. 5(2). 102–122. 5 indexed citations

Palmer, James L., Veronica C. Munk, G Vincze, et al.. (2008). 196: Cost-Effectiveness of Aliskiren as Add on to Losartan and Optimal Antihypertensive Therapy in Patients with Type 2 Diabetes, Hypertension and Nephropathy in the UK Setting. American Journal of Kidney Diseases. 51(4). B76–B76. 2 indexed citations

Munk, Veronica C., Lourdes Sánchez de Miguel, Andrea Banfi, et al.. (2007). Angiotensin II Induces Angiogenesis in the Hypoxic Adult Mouse Heart In Vitro Through an AT₂–B2 Receptor Pathway. Hypertension. 49(5). 1178–1185. 47 indexed citations

10.

Munk, Veronica C., et al.. (2004). A versatile in vitro assay for investigating angiogenesis of the heart. Experimental Cell Research. 300(2). 272–282. 17 indexed citations

11.

Kiefer, Florian W., et al.. (2003). Hypertension and Angiogenesis. Current Pharmaceutical Design. 9(21). 1733–1744. 55 indexed citations

12.

Gasparini, F., Hendrik Andres, Peter J. Flor, et al.. (2002). [3H]-M-MPEP, a Potent, Subtype-Selective Radioligand for the Metabotropic Glutamate Receptor Subtype 5. Bioorganic & Medicinal Chemistry Letters. 12(3). 407–409. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact